These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 16373285

  • 1. Octreotide in the treatment of refractory ascites of cirrhosis.
    Kalambokis G, Fotopoulos A, Economou M, Tsianos EV.
    Scand J Gastroenterol; 2006 Jan; 41(1):118-21. PubMed ID: 16373285
    [Abstract] [Full Text] [Related]

  • 2. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Bokharhii JA, Katsaraki A, Tsianos EV.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [Abstract] [Full Text] [Related]

  • 3. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F, Pantea L, Sniderman K.
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
    Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V.
    Hepatology; 2003 Jul; 38(1):258-66. PubMed ID: 12830009
    [Abstract] [Full Text] [Related]

  • 6. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R, Woodis CB.
    Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
    [Abstract] [Full Text] [Related]

  • 7. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.
    Berzigotti A, Magalotti D, Cocci C, Angeloni L, Pironi L, Zoli M.
    Dig Liver Dis; 2006 Feb; 38(2):138-42. PubMed ID: 16389001
    [Abstract] [Full Text] [Related]

  • 8. Refractory ascites: definition, pathogenesis and treatment.
    Laffi G, La Villa G, Pinzani M, Foschi M, Carloni V, Casini Raggi V, Gentilini P.
    Ann Ital Med Int; 1993 Feb; 8(1):38-46. PubMed ID: 8485009
    [Abstract] [Full Text] [Related]

  • 9. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, Tsianos EV.
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L, Villeneuve JP, Tran HK, Pomier-Layrargues G.
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [Abstract] [Full Text] [Related]

  • 12. Ascites in cirrhosis: a review of management and complications.
    Kuiper JJ, van Buuren HR, de Man RA.
    Neth J Med; 2007 Sep; 65(8):283-8. PubMed ID: 17890787
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS, Park GT, Kim YH, Shim SG, Kim JB, Lee OY, Choi HS, Hahm JS, Lee MH.
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Octreotide in the treatment of refractory ascites of cirrhosis.
    Leong RW, Jeffrey GP.
    Scand J Gastroenterol; 2006 Jun; 41(6):763; author reply 764. PubMed ID: 16716981
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
    Kalambokis G, Fotopoulos A, Economou M, Tsianos EV.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.